within Pharmacolibrary.Drugs.ATC.A;

model A07AA04_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 1.2 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,
    adminCount     = 1,
    Vd             = 0.00020999999999999998,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Streptomycin is an aminoglycoside antibiotic used to treat a variety of gram-negative and some gram-positive bacterial infections, notably tuberculosis. It is typically reserved for use in cases of tuberculosis and other specific infections due to resistance or intolerance to other agents. Streptomycin was historically very important but is now less commonly used due to the availability of newer antibiotics and risk of side effects.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult subjects following single intravenous infusion.</p><h4>References</h4><ol><li><p>Germovsek, E, et al., &amp; Sharland, M (2017). What do I need to know about aminoglycoside antibiotics?. <i>Archives of disease in childhood. Education and practice edition</i> 102(2) 89–93. DOI:<a href=&quot;https://doi.org/10.1136/archdischild-2015-309069&quot;>10.1136/archdischild-2015-309069</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27506599/&quot;>https://pubmed.ncbi.nlm.nih.gov/27506599</a></p></li><li><p>Sullins, AK, &amp; Abdel-Rahman, SM (2013). Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. <i>Paediatric drugs</i> 15(2) 93–117. DOI:<a href=&quot;https://doi.org/10.1007/s40272-013-0017-5&quot;>10.1007/s40272-013-0017-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23529866/&quot;>https://pubmed.ncbi.nlm.nih.gov/23529866</a></p></li><li><p>Zhu, M, et al., &amp; Peloquin, CA (2001). Population pharmacokinetics of intravenous and intramuscular streptomycin in patients with tuberculosis. <i>Pharmacotherapy</i> 21(9) 1037–1045. DOI:<a href=&quot;https://doi.org/10.1592/phco.21.13.1037.34625&quot;>10.1592/phco.21.13.1037.34625</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11560193/&quot;>https://pubmed.ncbi.nlm.nih.gov/11560193</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A07AA04_1;
